Roland Kappler

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 13

Top Topics

Systemic Lupus Erythematosus

Signaling Pathway

Top Venues

Hepatology communications

Clinical epigenetics

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Salih Demir, Negin Razizadeh, Émilie Indersie, Sophie Branchereau, Stefano Cairo, Roland Kappler
Targeting G9a/DNMT1 methyltransferase activity impedes IGF2-mediated survival in hepatoblastoma. Hepatology communications 8 (2) (2024)
Salih Demir, Negin Razizadeh, Émilie Indersie, Sophie Branchereau, Stefano Cairo, Roland Kappler
Targeting G9a/DNMT1 methyltransferase activity impedes IGF2-mediated survival in hepatoblastoma. Hepatology communications 8 (2) (2024)
Salih Demir, Negin Razizadeh, Émilie Indersie, Sophie Branchereau, Stefano Cairo, Roland Kappler
Targeting G9a/DNMT1 methyltransferase activity impedes IGF2-mediated survival in hepatoblastoma. Hepatology communications 8 (2) (2024)
Salih Demir, Negin Razizadeh, Émilie Indersie, Sophie Branchereau, Stefano Cairo, Roland Kappler
Targeting G9a/DNMT1 methyltransferase activity impedes IGF2-mediated survival in hepatoblastoma. Hepatology communications 8 (2) (2024)
Salih Demir, Negin Razizadeh, Émilie Indersie, Sophie Branchereau, Stefano Cairo, Roland Kappler
Targeting G9a/DNMT1 methyltransferase activity impedes IGF2-mediated survival in hepatoblastoma. Hepatology communications 8 (2) (2024)
Rebecca Maxwell, Beate Häberle, Roland Kappler, Dietrich von Schweinitz, Mark Rassner, Julia von Frowein, Irene Schmid
Hepatoblastoma Relapse-Findings from the German HB99 Trial and the German Liver Tumor Registry. Cancers 16 (4) (2024)
Rebecca Maxwell, Beate Häberle, Roland Kappler, Dietrich von Schweinitz, Mark Rassner, Julia von Frowein, Irene Schmid
Hepatoblastoma Relapse-Findings from the German HB99 Trial and the German Liver Tumor Registry. Cancers 16 (4) (2024)
Jessica Ritter, Kristina Lisec, Marina Klinner, Martina Heinrich, Dietrich von Schweinitz, Roland Kappler, Jochen Hubertus
Genetic Disruption of Cilia-Associated Signaling Pathways in Patients with VACTERL Association. Children (Basel, Switzerland) 10 (5) (2023)
Qian Li, Salih Demir, Álvaro Del Río-Álvarez, Rebecca Maxwell, Alexandra Wagner, Juan Carrillo-Reixach, Carolina Armengol, Christian Vokuhl, Beate Häberle, Dietrich von Schweinitz, Irene Schmid, Stefano Cairo, Roland Kappler
Targeting the Unwindosome by Mebendazole Is a Vulnerability of Chemoresistant Hepatoblastoma. Cancers 14 (17) (2022)
Alexandra Elisabeth Wagner, Thomas Schwarzmayr, Beate Häberle, Christian Vokuhl, Irene Schmid, Markus Kaller, Heiko Hermeking, Dietrich von Schweinitz, Roland Kappler
Erratum: Wagner, A.E., et al. SP8 Promotes an Aggressive Phenotype in Hepatoblastoma via FGF8 Activation. Cancers 2020, 12, 2294. Cancers 13 (3) (2021)
Julian Kolorz, Salih Demir, Adrian Gottschlich, Iris Beirith, Matthias Ilmer, Daniel Lüthy, Christoph Walz, Mario M Dorostkar, Thomas Magg, Fabian H Hauck, Dietrich von Schweinitz, Sebastian Kobold, Roland Kappler, Michael Berger
The Neurokinin-1 Receptor Is a Target in Pediatric Rhabdoid Tumors. Current oncology (Toronto, Ont.) 29 (1) (2021)
Alexandra Elisabeth Wagner, Thomas Schwarzmayr, Beate Häberle, Christian Vokuhl, Irene Schmid, Dietrich von Schweinitz, Roland Kappler
SP8 Promotes an Aggressive Phenotype in Hepatoblastoma via FGF8 Activation. Cancers 12 (8) (2020)
Alexander Beck, Franziska Trippel, Alexandra Wagner, Saskia Joppien, Max Felle, Christian Vokuhl, Thomas Schwarzmayr, Tim M Strom, Dietrich von Schweinitz, Gernot Längst, Roland Kappler
Overexpression of UHRF1 promotes silencing of tumor suppressor genes and predicts outcome in hepatoblastoma. Clinical epigenetics 10 (2018)